Category

Most Read

Most Read: Huafa Property Services Group, Nuvoton Technology, Seven & I Holdings, Toyota Motor, Kioxia Holdings , Taiwan Semiconductor (TSMC) – ADR, OCI Co, SK Square and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Huafa Property (982 HK): Buy With Both Hands
  • Yuanta/​P-Shares Taiwan Div+ ETF Rebalance Preview: Nuvoton Could Drop Some More
  • Updates on The Couche-Tard Deal for 7&I (3382 JP)
  • Toyota Partial Offer Results – What Next?
  • Kioxia IPO Early Re-Look – Better Placed This Time Around
  • Kioxia & Tokyo Metro: Japan’s Largest IPOs Since 2018 Expected This October
  • Huafa Prop (982 HK)’s CCASS Movements: Nothing To See Here
  • TSMC (2330.TT; TSM.US): 2024 Top Clients
  • KOSPI 200 December Rebalancing: Key Points to Watch for in Proactive Position Build-Up
  • Understanding Potential Issues Within SK Group from Hynix’s Kioxia CB Conversion


Huafa Property (982 HK): Buy With Both Hands

By David Blennerhassett

  • A state-owned Offeror pitching a lifetime high Offer Price – with a solid premium –  for an illiquid company? Sounds like a slam dunk.
  • Yet  property manager Huafa Property Services Group (982 HK) has perennially traded wide to Huafa Industrial Co., Ltd. Zhuhai (600325 CH)‘s terms. This is not justified. 
  • The Scheme Meeting/SGM is tomorrow (28 August), with payment on (or before) the 30 September. Or a gross/annualised return of 4%/46%. Buy here. Then buy some more. 

Yuanta/​P-Shares Taiwan Div+ ETF Rebalance Preview: Nuvoton Could Drop Some More

By Brian Freitas

  • With the review period complete, Nuvoton Technology (4919 TT) is a near certain deletion from the Yuanta/​P-Shares Taiwan Dividend Plus ETF in September.
  • Passive trackers will need to sell 20m shares in Nuvoton Technology (4919 TT). That is over 10% of float and the stock could continue to remain under pressure. 
  • The potential deletion still appears to be under positioned. There could be renewed selling in the stock over the next few weeks.

Updates on The Couche-Tard Deal for 7&I (3382 JP)

By Travis Lundy

  • Today saw the publication of three different articles regarding the Alimentation Couche-Tard (ATD CN) approach and offer to purchase all the shares of Seven & I Holdings (3382 JP) 
  • The first in the Nikkei said ATD could push offer a high price, even up to ¥8 trillion. The second mentioned debt financing being feasible because of prodigious cash flow.
  • The third in Bloomberg noted that 7&i had requested the government upgrade its FEFTA status to “core”, which would lead to a more burdensome/restrictive government approval process.

Toyota Partial Offer Results – What Next?

By Travis Lundy

  • Today after the close, Toyota Motor (7203 JP) reported the results of their ¥800bn Tender Offer Buyback, originally intended to repurchase 290.12mm shares from cross-holders. 
  • In the end, 343.83mm shares were tendered (53.71mm shares more than originally expected, worth about ¥150bn at Tender Price). That creates back-end “issues” which must be considered.
  • The resulting supply/demand profile is mixed, but on balance, I expect sees positive demand into the H1 earnings announcement. Watch for another buyback possibly announced then.

Kioxia IPO Early Re-Look – Better Placed This Time Around

By Sumeet Singh

  • Kioxia Holdings (6600 JP) aims to list in Japan by Oct 2024 at a valuation of over US$10bn, as per media reports. 
  • Kioxia is a manufacturer and a global leader in flash memory and solid state drives for smartphones, PCs, enterprise servers and data centers
  • In this note, we take an early look at the possible listing.

Kioxia & Tokyo Metro: Japan’s Largest IPOs Since 2018 Expected This October

By Dimitris Ioannidis

  • Kioxia and Tokyo Metro with valuations of ~$10bn and ~$4.6bn are expected to be listed in October 2024 and become the largest Japanese IPOs since Softbank Corp (9434 JP) in 2018.
  • Kioxia Holdings (6600 JP) is currently forecasted to fail fast entries of both Global indices due to low IPO free float. 
  • Tokyo Metro is expected to be added via fast-entry in one Global Index because of higher IPO free float. Forecasted demand of ~$140m is expected on the fifth trading day.

Huafa Prop (982 HK)’s CCASS Movements: Nothing To See Here

By David Blennerhassett

  • Ahead of Huafa Property Services Group (982 HK)‘s Scheme Meeting tomorrow, the 28th August, 42.57% of shares outstanding moved out of CCASS on the 8th July.
  • One argument for Huafa trading wide-ish to terms is due to “suspicious” CCASS moves between the Offer announcement and the vote. 
  • Some investors even cite the Golden Throat Holdings (6896 HK) debacle. This is not a Golden Throat situation. Not even close. It is decidedly less interesting and benign.

TSMC (2330.TT; TSM.US): 2024 Top Clients

By Patrick Liao


KOSPI 200 December Rebalancing: Key Points to Watch for in Proactive Position Build-Up

By Sanghyun Park

  • The momentum for getting ahead on positions with KOSPI 200 rebalancing is holding steady. With around 60% of the screening period behind us, it’s time to start preparing our positions.
  • The current rebalancing’s screened changes have a relatively lower price volatility, suggesting a stronger chance for more aggressive position build-up now compared to previous rebalancings.
  • Trading volumes vary greatly among these changes, affecting their passive impact sizes. Consider using different weights in basket trading instead of equal weights.

Understanding Potential Issues Within SK Group from Hynix’s Kioxia CB Conversion

By Sanghyun Park

  • Hynix’s potential 15% stake in Kioxia doesn’t violate the 20% rule because KFTC’s mandatory stake rule doesn’t apply to foreign investments.
  • SK Group may transfer Hynix’s 15% Kioxia stake to SK Square by splitting Hynix and merging its investment arm with SK Square for future AI investments.
  • SK Square may attract more attention than Hynix short-term, as Kioxia’s stake via Hynix could boost market expectations for value transfer to SK Square.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: Shin Kong Financial Holding, Asia Cement China, Yamaha Motor, Zomato, Shanghai Henlius Biotech , Shinko Electric Industries, Samsung Kodex Banks ETF, Huafa Property Services Group, PDD Holdings and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Shin Kong (2888.TW) And Taishin (2887.TW) Agree to Merge, But It Isn’t Clean, And It’s A Bad Price
  • Asia Cement (743 HK): 26th August Vote. Shareholders Should Reject Terms
  • Yamaha Motors (7272 JP) – Secondary Offering as Toyota Sells Down – Easy To Digest
  • Zomato: Index Inclusions & Passive Impact (Once Added to F&O)
  • Henlius (2696 HK): Was There Any Doubt?
  • Shinko Electric (6967) Deal Approval Delayed; From Here, Big Gap-, Small Break-, Some Delay-Risk
  • KRX Value-Up Index Will Have Two Separate Indices, Excellent & Promising, With 150 Constituents
  • Huafa Property (982 HK): Buy With Both Hands
  • Shinko Electric (6967 JP): Tender Start Timelines Delayed
  • PDD (PDD US): Stock Plunged After Excellent 2Q24 Result – Your Time to Buy


Shin Kong (2888.TW) And Taishin (2887.TW) Agree to Merge, But It Isn’t Clean, And It’s A Bad Price

By Travis Lundy

  • After rumours were rekindled a week earlier, on 22 August 2024, Taishin Financial Holding (2887 TT) and Shin Kong Financial Holding (2888 TT) announced they would merge.
  • The ratio is 0.6022 shares of Taishin for every share of Shin Kong putting NEWCO assets at about the level of Taiwan #3 CTBC Financial. That’s bad.
  • There’s history here. LOTS of history. This would need approvals from the FSC and FTC, but CTBC is already a spoiner, and the SKFH Board Meeting was anything but clean.

Asia Cement (743 HK): 26th August Vote. Shareholders Should Reject Terms

By David Blennerhassett

  • Back on the 5th June, Chinese cement play Asia Cement China (743 HK) announced a rubbish HK$3.22/share Offer from its parent Asia Cement (1102 TT).
  • This best & final cash Offer was a ~ 45% premium to undisturbed, and a 37% discount to FY23’s net cash. It’s a 39% discount to 1H24’s net cash.
  • The Scheme Doc is now out, with a 26th August independent shareholder vote. And payment (if it were to occur) on 20th September. The IFA (unsurprisingly) says fair and reasonable. 

Yamaha Motors (7272 JP) – Secondary Offering as Toyota Sells Down – Easy To Digest

By Travis Lundy

  • On Firday 23 August, Yamaha Motor (7272 JP) announced that three cross-holders would sell about 4.6% of the shares out in a secondary sale. 
  • MS&AD was expected. Toyota was probably expected. Yamaha Corp is a bit of a surprise. But it also frees up Yamaha Motor to sell down cross-holdings (top 2 are Toyota/Yamaha).
  • Given the price/guidance/dividend yield and limited size, this should be quite easy to place.

Zomato: Index Inclusions & Passive Impact (Once Added to F&O)

By Brian Freitas


Henlius (2696 HK): Was There Any Doubt?

By David Blennerhassett

  • Roughly six weeks ago, Shanghai Henlius Biotech (2696 HK) announced the scrip option condition was met. Just that Shanghai Fosun Pharmaceutical (2196 HK) (the Offeror) was weighing its options
  • This situation mirrored L’Occitane (973 HK)‘s (eventual) scrip option. And in place of Pleasant Lake in that transaction; Henlius has Loyal Valley Capital (5.8309% shareholder) behind the scenes.
  • Late Friday, Henlius updated the terms of Fosun’s Offer to now include the scrip option alternative. We expected nothing less. 1H24 results will also be out later today. 

Shinko Electric (6967) Deal Approval Delayed; From Here, Big Gap-, Small Break-, Some Delay-Risk

By Travis Lundy

  • Today after the close, Shinko Electric Industries (6967 JP) offered a progress report on the approvals for the JIC Consortium Tender Offer originally “scheduled” to start in late August 2024.
  • “Procedures and Steps Necessary under the competition laws of Vietnam and China have not been completed” so the Tender Offeror expects to commence the Tender Offer in/after late January 2025.
  • The announcement appears to suggest no update is likely for another five months or until the Tender Offer starts. That will introduce questions of further delay.

KRX Value-Up Index Will Have Two Separate Indices, Excellent & Promising, With 150 Constituents

By Sanghyun Park

  • KRX plans to launch the Value-Up Index as two separate indices: the “Excellent Value-Up Index” and the “Promising Value-Up Index.”
  • The universe will include 150 constituents from KOSPI 200 and KOSDAQ 150. Allocation between indices is undecided, with sector limits on number and weight confirmed.
  • The key indicators (ROE, PBR, shareholder return rate) remain unchanged. The Promising Index’s weights are undisclosed, but the Excellent Index favors financial and automotive stocks.

Huafa Property (982 HK): Buy With Both Hands

By David Blennerhassett

  • A state-owned Offeror pitching a lifetime high Offer Price – with a solid premium –  for an illiquid company? Sounds like a slam dunk.
  • Yet  property manager Huafa Property Services Group (982 HK) has perennially traded wide to Huafa Industrial Co., Ltd. Zhuhai (600325 CH)‘s terms. This is not justified. 
  • The Scheme Meeting/SGM is tomorrow (28 August), with payment on (or before) the 30 September. Or a gross/annualised return of 4%/46%. Buy here. Then buy some more. 

Shinko Electric (6967 JP): Tender Start Timelines Delayed

By Arun George

  • Shinko Electric Industries (6967 JP) pre-conditional tender offer from the JIC alliance is JPY5,920 per share. The tender start has been delayed from late August to around late January 2025.
  • The delay was due to outstanding China SAMR and Vietnam regulatory approvals. The stretched timeline suggests that SAMR will likely conditionally approve the deal. 
  • While Ibiden Co Ltd (4062 JP)’s underperformance lowers the deal’s break price, timing, not break risk, remains the key concern. At the last close, the gross/annualised spread was 3.7%/7.5%. 

PDD (PDD US): Stock Plunged After Excellent 2Q24 Result – Your Time to Buy

By Ming Lu

  • The stock plunged today after the announcement of excellent performance for 2Q24.
  • In 2Q24, revenue grew by 86% YoY and the operating margin improved 10 percentage points YoY.
  • We believe investors should buy, as it is just a tactic from major stock sellers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: ESR Group , Shin Kong Financial Holding, Doosan Bobcat Inc, Trent Ltd, Hitachi Energy India, Shift Inc, Divi’s Laboratories, Bharat Heavy Electricals, Zomato, Yamaha Motor and more

By | Daily Briefs, Most Read

In today’s briefing:

  • ESR Group (1821 HK): A Rumoured Offer Price Surfaces
  • Shin Kong (2888.TW) And Taishin (2887.TW) Agree to Merge, But It Isn’t Clean, And It’s A Bad Price
  • Korea FSS Chief Calls for 10% Premium/Discount on Doosan Merger, Boosting Swap Spread to 30%
  • NIFTY50 Index Rebalance: Trent, BEL to Replace Divi’s Lab, LTIMindtree
  • NIFTY MIDCAP150 Index Rebalance: 19 Changes a Side; Lots of Overlap with Other Index Flow
  • Shift (3697): Profitability Rebound Underway
  • Quiddity NIFTY Sep 24 Rebal: US$647mn One-Way Capping for NIFTY Next 50; All Changes Were Predicted
  • NIFTY NEXT50 Index Rebalance: 7 Changes on Expected Lines
  • Zomato: Index Inclusions & Passive Impact (Once Added to F&O)
  • Yamaha Motors Placement – A Relatively Small Cross-Shareholding Unwind


ESR Group (1821 HK): A Rumoured Offer Price Surfaces

By Arun George

  • A media outlet that Reports on Deals reported that the consortium will offer HK$14.50 per share, a 22.1% and 61.8% premium to the last close (HK$11.88) and undisturbed price (HK$8.96).
  • While not a knockout offer, the consortium’s impending binding proposal suggests confidence that the offer price and structure would gain the support of the substantial shareholders. 
  • The downside to a deal break is low as ESR’s valuation is undemanding. Its forward EV/EBITDA multiple is at a 30% discount to the median peers’ multiple.

Shin Kong (2888.TW) And Taishin (2887.TW) Agree to Merge, But It Isn’t Clean, And It’s A Bad Price

By Travis Lundy

  • After rumours were rekindled a week earlier, on 22 August 2024, Taishin Financial Holding (2887 TT) and Shin Kong Financial Holding (2888 TT) announced they would merge.
  • The ratio is 0.6022 shares of Taishin for every share of Shin Kong putting NEWCO assets at about the level of Taiwan #3 CTBC Financial. That’s bad.
  • There’s history here. LOTS of history. This would need approvals from the FSC and FTC, but CTBC is already a spoiner, and the SKFH Board Meeting was anything but clean.

Korea FSS Chief Calls for 10% Premium/Discount on Doosan Merger, Boosting Swap Spread to 30%

By Sanghyun Park

  • FSS Governor Lee challenged the legality of the Robotics-Bobcat merger ratio, citing Article 176-5 of the Capital Markets Act, allowing a 10% premium or discount.
  • Following the FSS Governor’s statements, Doosan must likely apply a 10% premium/discount to the Robotics-Bobcat merger, creating a 30% spread based on current stock prices.
  • Doosan may still revise or cancel the merger, but the FSS Governor’s comments might boost Bobcat short-term. Given the uncertainty, aggressive trading is risky.

NIFTY50 Index Rebalance: Trent, BEL to Replace Divi’s Lab, LTIMindtree

By Brian Freitas


NIFTY MIDCAP150 Index Rebalance: 19 Changes a Side; Lots of Overlap with Other Index Flow

By Brian Freitas

  • There are 19 changes a side for the NIFTY Midcap 150 Index at the September rebalance. There are many stocks with same-way flows from passive trackers of other indices.
  • Estimated one-way turnover is 9.8% resulting in a one-way trade of INR 8.2bn (US$98m). With US$40.1bn tracking the index actively, the impact on the stocks will be much larger.
  • The adds have outperformed the deletes this year, though near-term performance has been meh. There was a similar trend in March and the adds could outperform nearer to implementation.

Shift (3697): Profitability Rebound Underway

By Michael Allen

  • A massive shortage of IT professionals combined with Shift’s overwhelming dominance of the labor market should drive 20% annual revenue growth through 2030. 
  • But Shift missed consensus profitability estimates 3 consecutive quarters, and the share price is down 67% in 12 months, compared to an 18% rise in the median peer. 
  • In our view, a recovery in profitability is already underway, and shares are at least 45% undervalued

Quiddity NIFTY Sep 24 Rebal: US$647mn One-Way Capping for NIFTY Next 50; All Changes Were Predicted

By Janaghan Jeyakumar, CFA

  • The September 2024 Rebalance results for the NIFTY broad market Indices were announced after the close on Friday 23rd August 2024.
  • There will be two changes for NIFTY 50 and five changes for NIFTY 100 during the September 2024 index rebal event. All of these changes were as predicted. 
  • All NIFTY 50 and NIFTY 100 changes will also be reflected in the NIFTY Next 50 index which could see US$647mn one-way capping flows.

NIFTY NEXT50 Index Rebalance: 7 Changes on Expected Lines

By Brian Freitas

  • There are 7 changes for the NSE Nifty Next 50 Index (NIFTYJR INDEX) that will be implemented at the close on 27 September. Changes are on expected lines.
  • Estimated one-way turnover for the Nifty Next 50 Index (NIFTYJR INDEX) is 19.6% resulting in a one-way trade of INR 63.64bn (US$759m). Many stocks have over 1x ADV to trade.
  • The adds have outperformed the deletes this year but there has been big underperformance over the last month as stocks expected to benefit from rural spending have rallied.

Zomato: Index Inclusions & Passive Impact (Once Added to F&O)

By Brian Freitas


Yamaha Motors Placement – A Relatively Small Cross-Shareholding Unwind

By Sumeet Singh

  • A group of shareholders aims to raise around US$330m via selling around 3.6% of Yamaha Motor (7272 JP).
  • This will be another cross-shareholding unwind and hence, won’t be a huge surprise, although the stock hasn’t been doing particularly well lately.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: JD.com , Westgold Resources, Techwing Inc, Huaneng Lancang River Hydropow, China Traditional Chinese Medicine, ESR Group , Shanghai Henlius Biotech , Vector, Canara Bank, CMES AI Robotics and more

By | Daily Briefs, Most Read

In today’s briefing:

  • JD.com (9618 HK): Index Implications of Walmart Placement
  • S&P/​​​​​​​​​ASX Index Rebalance Preview: Review Period Nearly Done; Big Impact Changes
  • FnGuide Semiconductor Top10 Index Rebalance Preview: Two Changes Likely in October
  • China A50 ETFs Rebalance Preview: Two High Probability Changes in Sep
  • (Mostly) Asia-Pac M&A: APM Human Services, TCM, Alps Logistics, Fancl, Jeisys Medical, PropertyGuru
  • ESR Group (1821 HK): A Rumoured Offer Price Surfaces
  • Henlius (2696 HK): Share Alternative Facilitates the Vote
  • Japan Tobacco/Vector Group: Possible Bump-Up?
  • NIFTY Bank Index Rebalance: Canara Bank IN; Bandhan Bank OUT
  • CMES AI Robotics IPO Preview


JD.com (9618 HK): Index Implications of Walmart Placement

By Brian Freitas

  • Media reports indicate that Walmart (WMT US) is looking to sell 144.5m shares of JD.com (JD US) to raise up to US$3.74bn. That would be substantially all of its stake.
  • There will be passive buying from global index trackers at the time of settlement of the placement shares and could absorb around 12% of the placement shares.
  • There will be no passive buying from HSI, HSCEI, HSTECH and HSIII trackers in the short-term. An increase in CCASS holdings should result in passive buying in December.

S&P/​​​​​​​​​ASX Index Rebalance Preview: Review Period Nearly Done; Big Impact Changes

By Brian Freitas

  • With 2 trading days left in the review period, there could be 30 adds/deletes across the S&P/ASX family of indices in September.
  • Passive trackers will need to trade a lot of stock in the forecast changes, with the impact being especially large for the changes to the S&P/ASX 200 and S&P/ASX 300.
  • The forecast adds have hugely outperformed the forecast deletes. Borrow recall on the deletes and increased borrow availability on the adds could result in underperformance following announcement of the changes.

FnGuide Semiconductor Top10 Index Rebalance Preview: Two Changes Likely in October

By Brian Freitas



(Mostly) Asia-Pac M&A: APM Human Services, TCM, Alps Logistics, Fancl, Jeisys Medical, PropertyGuru

By David Blennerhassett


ESR Group (1821 HK): A Rumoured Offer Price Surfaces

By Arun George

  • A media outlet that Reports on Deals reported that the consortium will offer HK$14.50 per share, a 22.1% and 61.8% premium to the last close (HK$11.88) and undisturbed price (HK$8.96).
  • While not a knockout offer, the consortium’s impending binding proposal suggests confidence that the offer price and structure would gain the support of the substantial shareholders. 
  • The downside to a deal break is low as ESR’s valuation is undemanding. Its forward EV/EBITDA multiple is at a 30% discount to the median peers’ multiple.

Henlius (2696 HK): Share Alternative Facilitates the Vote

By Arun George

  • Shanghai Fosun Pharmaceutical (Group) (2196 HK) announced the Shanghai Henlius Biotech (2696 HK) share alternative offer, subject to proration due to a cap of 8% of outstanding shares. 
  • The share alternative offer was necessary to facilitate the vote as the HK$24.60 offer is half the HK$49.60 IPO price. 
  • The co-founders, HenLink and LVC, will likely tender some or all their shares for scrip. At the last close and for the December-end payment, the gross/annualised spread is 7.4%/17.9%.

Japan Tobacco/Vector Group: Possible Bump-Up?

By Jesus Rodriguez Aguilar

  • JT plans to acquire 100% of Vector Group at $15.00/share, a 29.9% premium. The offer requires over 50% acceptance, with Board support and completion expected by late 2024, pending approvals.
  • The shares go ex-dividend on August 30, with payment on September 12. Adjusted for the dividend, shares trade at a -0.4% gross spread. My fair value estimated is $15.92/share.
  • Consensus sets a target price of $16/share. JT may consider raising its offer to this level (6.67%), especially if they see Vector as a strong long-term investment.

NIFTY Bank Index Rebalance: Canara Bank IN; Bandhan Bank OUT

By Brian Freitas


CMES AI Robotics IPO Preview

By Douglas Kim

  • CMES AI Robotics is getting ready to complete its IPO on KOSDAQ in October. The expected IPO price is 20,000 won to 24,000 won. 
  • CMES provides intelligent robot solutions that combine artificial intelligence (AI) and three-dimensional (3D) vision technology. CMES’s core technologies include 3D vision sensors and image processing algorithms. 
  • Robotics related IPOs have generated enormous interest in Korea. Although CMES is a small cap name, this robotics related IPO is also likely to garner high interest as well. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: Alibaba Group Holding , Seven & I Holdings, China Traditional Chinese Medicine, Hanwha Galleria , Hanwha Corporation, Innovent Biologics Inc, Hanwha Aerospace, Grifols SA and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?
  • Alibaba (9988 HK): Dual Primary Listing & Potential Southbound Flows
  • Couche-Tard Bid for 7&I (3382) – FEFTA and Economic Security
  • TCM (570 HK): Profit Warning Is No Biggie
  • A Tender Offer to Purchase a 17.5% Stake in Hanwha Galleria by Kim Dong-Sun
  • StubWorld: More Partial Offers In The Hanwha Group Complex
  • Innovent Biologics (1801 HK) Adds to Its Oncology Portfolio
  • Both Hanwha Aerospace Spinoffs Remain in KOSPI 200: Trading Value Gap Between Trading Suspension
  • Examining the Severity of Proration Risk in the Hanwha Galleria Tender Offer
  • Brookfield/Grifols: Update & Recap, Spread, Discount


Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?

By Brian Freitas

  • In its last update, Alibaba Group announced that the company was preparing for its primary listing in Hong Kong and the process was expected to complete by the end August.
  • The Board meets on 14 August to approve results for the three months ending June. Could there be an announcement on the dual primary listing too?
  • Mainland Chinese own between 3.5%-15.5% of companies that converted from Secondary to Dual-Primary in the last few years. Similar buying in Alibaba could take the stock higher from here. 

Alibaba (9988 HK): Dual Primary Listing & Potential Southbound Flows

By Brian Freitas

  • Along with its fiscal 2024 results, Alibaba (9988 HK) announced that they were preparing for their primary listing in Hong Kong and the conversion was expected to complete by August.
  • If the conversion is completed by the end of August, Alibaba (9988 HK) could be added to Southbound Stock Connect in September and that could bring in significant flows.
  • We do not forecast any passive inflows due to the change with Alibaba Group Holding (9988 HK) capped at 8% of the HSI, HSCEI and HSTECH indices.

Couche-Tard Bid for 7&I (3382) – FEFTA and Economic Security

By Travis Lundy

  • The largest potential inbound cross-border M&A in years – for a national champion no less – gets a lot of press coverage. 
  • This morning, a Nikkei article noted Alimentation Couche-Tard (ATD CN) was likely to need “prior approval” from Japanese regulatory authorities for its takeover “the Nikkei has learned.”
  • It wasn’t difficult for the Nikkei to learn that. METI publishes a FEFTA List. 7&i has been on it for years as Type II Designated Business, requiring prior approval.

TCM (570 HK): Profit Warning Is No Biggie

By David Blennerhassett

  • China Traditional Chinese Medicine (570 HK) flagged a 60-70% drop in its 1H24E net profit versus 1H23, due to reduced sales/profit of TCM concentrate, bad debt provisions, and remedial taxes. 
  • MAC triggers? No – Sinopharm won’t exercise such right, even if one was ostensibly triggered. I’d be surprised if Sinopharm wasn’t fully aware of TCM’s underlying operations. 
  • Get involved on any dips today. Trading wide at a 11.7%/38.7% gross/annualised spread, assuming Dec-end payment.

A Tender Offer to Purchase a 17.5% Stake in Hanwha Galleria by Kim Dong-Sun

By Douglas Kim

  • It was announced that a tender offer to purchase a 17.54% stake in Hanwha Galleria has been launched by Kim Dong-Sun (Vice President at Hanwha Galleria).
  • Tender offer price is 1,600 won per share, which is 22.8% higher than the closing price on 22 August. Tender offer amount is 54.4 billion won. 
  • On 23 August, Hanwha Galleria’s share price is likely to rise close to the tender offer price as many investors believe the tender offer is likely to be successful. 

StubWorld: More Partial Offers In The Hanwha Group Complex

By David Blennerhassett

  • After the Kim family-backed Hanwha Energy completed Hanwha Corporation‘s Partial Offer last month, Hanwha Galleria (452260 KS)‘s VP Kim Dong-seon has now launched a Partial Offer for 17.5% in Galleria. 
  • Preceding my comments on Hanwha are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Innovent Biologics (1801 HK) Adds to Its Oncology Portfolio

By Avien Pillay

  • Dupert, a drug for the special treatment of non-small cell cancer has been approved by the NMPA.
  • In 2022, China recorded the highest number of new cancer cases, and their exceptional high incidence of smoking is of particular concern.
  • Innovent’s portfolio of nine oncology drugs is very attractive in the biggest cancer market.

Both Hanwha Aerospace Spinoffs Remain in KOSPI 200: Trading Value Gap Between Trading Suspension

By Sanghyun Park

  • KRX announced that both Hanwha Aerospace and the new Hanwha Industrial Solutions will be added to the KOSPI 200.
  • Since 2020, two K200 spinoffs had both companies remain: DL Holdings and DL E&C in January 2021, and SK Telecom and SK Square in November 2021, with notable value increases.
  • This trade isn’t risk-free and requires a sophisticated hedge setup, but the trading opportunities from this flow situation are worth close attention.

Examining the Severity of Proration Risk in the Hanwha Galleria Tender Offer

By Sanghyun Park

  • The Hanwha Galleria tender offer has no cancellation risk but carries proration risk, keeping the spread at around 7%.
  • For Hanwha Galleria, most floating shares are held by retail investors, and the smaller float size compared to Hansol Logistics further reduces proration risk.
  • Even though the actual trading volume might be a concern, it’s still worth thinking about going for an aggressive strategy to take advantage of the spread, which is around 7%.

Brookfield/Grifols: Update & Recap, Spread, Discount

By Jesus Rodriguez Aguilar

  • Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private acquisition of Grifols SA (GRF SM).
  • Considering a €10.18/share possible offer price (institutionals are seeking €12), the A shares are trading at a 7.3% gross spread and are pricing a 62.5% possibility of deal completion.
  • The preferreds trading at 17.5% discount vs ordinary shares should be favored in case of takeover, with Long B shares/short A shares my preferred way to get involved.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: Alibaba Group Holding , JD.com , Greatview Aseptic Packaging, Seven & I Holdings, China Traditional Chinese Medicine, Westgold Resources, Workday Inc Class A, SK Innovation, Eoflow, Hanwha Galleria and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?
  • JD.com (9618 HK): Index Implications of Walmart Placement
  • GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk
  • Couche-Tard Bid for 7&I (3382) – FEFTA and Economic Security
  • TCM (570 HK): Profit Warning Is No Biggie
  • S&P/​​​​​​​​​ASX Index Rebalance Preview: Review Period Nearly Done; Big Impact Changes
  • Quiddity Leaderboard S&P500 Sep 24 Rebal: Palantir, Apollo, Workday Racing for Mega$ Flows
  • NPS Will Vote Against the Merger Between SK Innovation and SK E&S
  • Insulet Launches a Patent Lawsuit Against Eoflow in Europe
  • A Tender Offer to Purchase a 17.5% Stake in Hanwha Galleria by Kim Dong-Sun


Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?

By Brian Freitas

  • In its last update, Alibaba Group announced that the company was preparing for its primary listing in Hong Kong and the process was expected to complete by the end August.
  • The Board meets on 14 August to approve results for the three months ending June. Could there be an announcement on the dual primary listing too?
  • Mainland Chinese own between 3.5%-15.5% of companies that converted from Secondary to Dual-Primary in the last few years. Similar buying in Alibaba could take the stock higher from here. 

JD.com (9618 HK): Index Implications of Walmart Placement

By Brian Freitas

  • Media reports indicate that Walmart (WMT US) is looking to sell 144.5m shares of JD.com (JD US) to raise up to US$3.74bn. That would be substantially all of its stake.
  • There will be passive buying from global index trackers at the time of settlement of the placement shares and could absorb around 12% of the placement shares.
  • There will be no passive buying from HSI, HSCEI, HSTECH and HSIII trackers in the short-term. An increase in CCASS holdings should result in passive buying in December.

GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk

By David Blennerhassett

  • To say Greatview Aseptic Packaging (468 HK)‘s management and Shandong Xinjufeng (301296 CH) (XJF) don’t get along is an understatement. GAPack has labelled XJF’s pre-conditional Offer hostile and unwelcome.
  • Last night (6th August), co-founders Jeff Bi and Gang Hong tabled a non-binding Offer. No price was mentioned. Collectively they hold 14.72% of shares out compared to XJF’s 26.8%.
  • A firm Offer (and price) would have been welcome, and this probably reflects on-going funding negotiations. But the announcement will give minorities pause if/when tendering into XJF’s Offer.

Couche-Tard Bid for 7&I (3382) – FEFTA and Economic Security

By Travis Lundy

  • The largest potential inbound cross-border M&A in years – for a national champion no less – gets a lot of press coverage. 
  • This morning, a Nikkei article noted Alimentation Couche-Tard (ATD CN) was likely to need “prior approval” from Japanese regulatory authorities for its takeover “the Nikkei has learned.”
  • It wasn’t difficult for the Nikkei to learn that. METI publishes a FEFTA List. 7&i has been on it for years as Type II Designated Business, requiring prior approval.

TCM (570 HK): Profit Warning Is No Biggie

By David Blennerhassett

  • China Traditional Chinese Medicine (570 HK) flagged a 60-70% drop in its 1H24E net profit versus 1H23, due to reduced sales/profit of TCM concentrate, bad debt provisions, and remedial taxes. 
  • MAC triggers? No – Sinopharm won’t exercise such right, even if one was ostensibly triggered. I’d be surprised if Sinopharm wasn’t fully aware of TCM’s underlying operations. 
  • Get involved on any dips today. Trading wide at a 11.7%/38.7% gross/annualised spread, assuming Dec-end payment.

S&P/​​​​​​​​​ASX Index Rebalance Preview: Review Period Nearly Done; Big Impact Changes

By Brian Freitas

  • With 2 trading days left in the review period, there could be 30 adds/deletes across the S&P/ASX family of indices in September.
  • Passive trackers will need to trade a lot of stock in the forecast changes, with the impact being especially large for the changes to the S&P/ASX 200 and S&P/ASX 300.
  • The forecast adds have hugely outperformed the forecast deletes. Borrow recall on the deletes and increased borrow availability on the adds could result in underperformance following announcement of the changes.

Quiddity Leaderboard S&P500 Sep 24 Rebal: Palantir, Apollo, Workday Racing for Mega$ Flows

By Travis Lundy

  • The S&P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.
  • In this insight, we take a look at the upcoming constituent changes in the run up to the September 2024 index rebal event.
  • We expect two regular changes in September 2024. There are also several live M&A events which could trigger intra-review index changes in the late-2024/early-2025.

NPS Will Vote Against the Merger Between SK Innovation and SK E&S

By Douglas Kim

  • NPS will vote against the merger between SK Innovation and SK E&S, mainly due to significant concerns about destroying shareholder value (especially for SK Innovation shareholders). 
  • Sustinvest also recommended that institutional investors vote against this merger, citing that the merger ratio between SK Innovation and SK E&S is disadvantageous to SK Innovation’s general shareholders.
  • If NPS exercises its appraisal rights, this could put a knife in the wheel of the M&A merger between SK Innovation and SK E&S. 

Insulet Launches a Patent Lawsuit Against Eoflow in Europe

By Douglas Kim

  • Eoflow announced Insulet had filed an injunction on 3 July against Eoflow and Menarini requesting a ban on the manufacture, sale, distribution, and use of EOPatch in 17 European countries.
  • Given that Eoflow should have reported this event earlier, this is likely to result in further loss of confidence on Eoflow by many investors in the near term. 
  • If Eoflow is able to complete its rights offering (albeit lower amount than proposed), this could boost its chances to become a formidable competitor to Insulet on a global basis. 

A Tender Offer to Purchase a 17.5% Stake in Hanwha Galleria by Kim Dong-Sun

By Douglas Kim

  • It was announced that a tender offer to purchase a 17.54% stake in Hanwha Galleria has been launched by Kim Dong-Sun (Vice President at Hanwha Galleria).
  • Tender offer price is 1,600 won per share, which is 22.8% higher than the closing price on 22 August. Tender offer amount is 54.4 billion won. 
  • On 23 August, Hanwha Galleria’s share price is likely to rise close to the tender offer price as many investors believe the tender offer is likely to be successful. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: JD.com , Hang Seng Index, China Traditional Chinese Medicine, Guzman Y Gomez, Webjet Ltd, Techwing Inc, Eoflow, Alps Logistics, LG Electronics, DB Hitek Co., Ltd. and more

By | Daily Briefs, Most Read

In today’s briefing:

  • JD.com (9618 HK): Index Implications of Walmart Placement
  • Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)
  • China Traditional Chinese Medicine (570 HK): Never a Dull Moment as Profit Warning Lands
  • Guzman Y Gomez (GYG AU): Free Float to Determine Index Inclusion
  • Thoughts On Webjet (WEB AU)’s Demerger
  • FnGuide Semiconductor Top10 Index Rebalance Preview: Two Changes Likely in October
  • Eoflow: Rights Offering of 82 Billion Won and [Medtronic & Eoflow – Don’t You Forget About Me]
  • Logisteed/KKR Bigly Bid for Alps Logistics (9055) Goes Live Tomorrow. Still A Shocking Multiple
  • LG Electronics’ Value-Up Disclosure Today: Impact on Initial Flow Sizing for the Value-Up Index
  • Trading Situation Arising from Local Pensions’ Unusual Buying of DB HiTek


JD.com (9618 HK): Index Implications of Walmart Placement

By Brian Freitas

  • Media reports indicate that Walmart (WMT US) is looking to sell 144.5m shares of JD.com (JD US) to raise up to US$3.74bn. That would be substantially all of its stake.
  • There will be passive buying from global index trackers at the time of settlement of the placement shares and could absorb around 12% of the placement shares.
  • There will be no passive buying from HSI, HSCEI, HSTECH and HSIII trackers in the short-term. An increase in CCASS holdings should result in passive buying in December.

Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)

By Brian Freitas

  • In a surprise (maybe should not have been!), there are no constituent changes for the Hang Seng Index (HSI INDEX) in September. However, there are float and capping changes.
  • Estimated one-way turnover is 1% and estimated round-trip trade is HK$3.73bn (US$478m). There are no stocks with over +/-0.5x ADV to trade but flows could add to/offset other index flows.
  • We remain at 82 index constituents and the road to 100 constituents appears to be a long drawn out torturous one. At this glacial pace, could be an eternity away.

China Traditional Chinese Medicine (570 HK): Never a Dull Moment as Profit Warning Lands

By Arun George

  • China Traditional Chinese Medicine (570 HK) profit warning notes that the 1H24 net profit would decrease by 60%-70% YoY due to pricing pressure, higher impairment losses and remedial taxes. 
  • The profit warning could pose a risk to the scheme, as the consortium can withdraw if there is an adverse material change in China TCM’s profits or prospects.
  • If there were a danger of triggering the MAC clause, the consortium would not have made the regulatory submissions. The flip side is that the warning helps the shareholders vote. 

Guzman Y Gomez (GYG AU): Free Float to Determine Index Inclusion

By Brian Freitas

  • Guzman Y Gomez (GYG AU) listed on 20 June and is eligible for inclusion in the S&P/ASX family of indices at the September rebalance.
  • Whether the stock is included in indices depends on the index providers estimate of free float. We expect index providers to assign floats of between 25-35% for the stock.
  • Inclusion in one global index could come in November and another in December. Inclusion in the S&P/ASX indices will depend on whether float is higher than 30% or lower.

Thoughts On Webjet (WEB AU)’s Demerger

By David Blennerhassett

  • Back on the 22 May, global travel outfit Webjet (WEB AU)  announced it was exploring the separation of its two divisions – Webjet and Webjet B2C – via a demerger. 
  • If the demerger is implemented, shareholders will receive one Webjet B2C share for every Webjet share; plus retain their existing shares in Webjet (to be renamed WEB Travel Group).
  • A demerger booklet has been dispatched, with a 17th September vote on the in-specie distribution. If approved, WEB Travel (ex-entitlement) and Webjet B2C commence trading on the 23rd September.  

FnGuide Semiconductor Top10 Index Rebalance Preview: Two Changes Likely in October

By Brian Freitas


Eoflow: Rights Offering of 82 Billion Won and [Medtronic & Eoflow – Don’t You Forget About Me]

By Douglas Kim

  • After the market close on 21 August, Eoflow (294090 KS) announced a rights offering capital raise of 9.1 million new shares, representing share dilution of 23%.
  • Based on the expected rights offering issue price of 9,040 won, the company is expected to raise 82.2 billion won in this capital raise. 
  • Eoflow has monthly cash burn rate of about 3.3 billion won. If the rights offering is successful, it would have adequate capital resources for about a couple of years. 

Logisteed/KKR Bigly Bid for Alps Logistics (9055) Goes Live Tomorrow. Still A Shocking Multiple

By Travis Lundy

  • The Logisteed/KKR entity received its approvals between the last week of July and this past week, and told Alps Logistics (9055 JP) it wanted to launch its tender 22 August.
  • It will do so. Approvals were reasonably quick (as expected) and the Special Committee and Board decided nothing material had changed. No reason to change their opinion.
  • This is still a HUGE price. And everyone will be out by mid-October if they want. This is an easy deal. And a GIGANTIC win for minorities.

LG Electronics’ Value-Up Disclosure Today: Impact on Initial Flow Sizing for the Value-Up Index

By Sanghyun Park

  • LG Electronics aims for 7% growth, a 7x EV/EBITDA multiple, and a ₩1,000 DPS with a 25% payout ratio, likely disclosing details by late October or early November.
  • LG Electronics’ value-up disclosure highlights major non-financial companies’ participation before the value-up index launch, driven by regulatory pressure and concerns about index inclusion.
  • Samsung and Hyundai are likely to disclose value-up plans by early September, prompting an upward revision of flow size predictions for the value-up index launch.

Trading Situation Arising from Local Pensions’ Unusual Buying of DB HiTek

By Sanghyun Park

  • From early June until yesterday, local pension funds have purchased nearly 4% of DB HiTek’s SO. This places DB HiTek in a dominant first position in their net buying list.
  • The timing of local pension funds beginning to buy DB HiTek coincidentally aligns with May 22, when DB Inc was requested by the KFTC to transition into a holding company.
  • Focus on potential price impact from DB Inc.’s buying and value-up index inflows. Considering a relative overweight in DB HiTek may be strategic despite some risk.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: Seven & I Holdings, Hang Seng Index, Korea Stock Exchange KOSPI 200, Colowide Co Ltd, KB Financial ADR, Iriso Electronics, Guzman Y Gomez and more

By | Daily Briefs, Most Read

In today’s briefing:

  • MEGA M&A! 7&I (3382 JP) Gets Non-Binding Bid from Alimentation Couche-Tard (ATD CN)
  • Seven & I Holdings (3382 JP): Couche-Tard “friendly” Proposal Likely to Go Nowhere
  • Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)
  • Korea FSS Releases Final Guidelines for Short Selling Compliance: Trading Implications
  • Colowide Placement – Needs a Very Large Correction
  • Couche-Tard Targets Seven & I: Seven & I’s Pride on the Line
  • COLOWIDE (7616) – UGLY Register On Expensive Co Needs a Capital Construct Upgrade, Won’t Get It Here
  • Trading Considerations for Won Appreciation & Korean ADR Premium Volatility
  • Iriso Electronics (6908 JP): Murakami Becomes a Substantial Shareholder
  • Guzman Y Gomez (GYG AU): Free Float to Determine Index Inclusion


MEGA M&A! 7&I (3382 JP) Gets Non-Binding Bid from Alimentation Couche-Tard (ATD CN)

By Travis Lundy

  • Today, part-way through the day, the Nikkei ran an article saying that Alimentation Couche-Tard (ATD CN) had made a confidential non-binding proposal to buy Seven & I Holdings (3382 JP)
  • 7&i shares obviously went up (limit up in a hurry, staying there, large size traded limit up at close). 
  • Now things get complicated. 7&i has said they received a non-binding proposal for all the shares. There will be a Special Committee of all Independent Directors. All stakeholders will matter. 

Seven & I Holdings (3382 JP): Couche-Tard “friendly” Proposal Likely to Go Nowhere

By Arun George

  • Seven & I Holdings (3382 JP) shares rose 22.7% as it confirmed media reports that it had received a confidential, non-binding preliminary proposal from Alimentation Couche-Tard (ATD CN)
  • The interest is unsurprising due to the weak share price performance. Since ValueAct’s open letter on 25 January 2022, the shares are up 5.2% vs. the Nikkei 225 up 38.0%.
  • Couche-Tard aims for a friendly offer, which is challenging as it requires support from the founder’s family and the Japanese government. Therefore, the probability of a binding proposal is low.  

Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)

By Brian Freitas

  • In a surprise (maybe should not have been!), there are no constituent changes for the Hang Seng Index (HSI INDEX) in September. However, there are float and capping changes.
  • Estimated one-way turnover is 1% and estimated round-trip trade is HK$3.73bn (US$478m). There are no stocks with over +/-0.5x ADV to trade but flows could add to/offset other index flows.
  • We remain at 82 index constituents and the road to 100 constituents appears to be a long drawn out torturous one. At this glacial pace, could be an eternity away.

Korea FSS Releases Final Guidelines for Short Selling Compliance: Trading Implications

By Sanghyun Park

  • This final guideline formalizes earlier drafts by the FSS. Though not strictly mandatory, its detailed requirements mean it functions as a de facto rule that must be followed closely.
  • The new, stringent requirements are likely to eliminate common stock borrowing practices in Korea, making timely transactions difficult.
  • New trading patterns and market flows may emerge when short selling resumes in April, with increased importance of borrow balance data and potential rise in counter-flow trading.

Colowide Placement – Needs a Very Large Correction

By Sumeet Singh

  • Colowide Co Ltd (7616 JP) aims to raise around US$230m in order to fund its prospective M&A transactions over the next few years
  • While the company has undertaken a number of M&A transactions in the past, it hasn’t clearly stated its intended targets for this round.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Couche-Tard Targets Seven & I: Seven & I’s Pride on the Line

By Oshadhi Kumarasiri

  • It was reported yesterday that Alimentation Couche-Tard (ATD CN) has put forward a bold proposal to acquire Seven & I Holdings (3382 JP).
  • The offer price remains undisclosed, but the market may be anticipating a significant premium based on the share price movement following the news.
  • However, we believe the offer price could fall short of market expectations, and it is likely that Seven & i will reject the proposal.

COLOWIDE (7616) – UGLY Register On Expensive Co Needs a Capital Construct Upgrade, Won’t Get It Here

By Travis Lundy

  • Colowide Co Ltd (7616 JP) is an industrial fastish-food operator in Japan. They sell several dozen kinds of cuisine under several dozen brands, owned and franchised in Japan and overseas.
  • The company “philosophy” is “Everything we do is for our customers and employees.” The stock is up 30% in 10yrs. It pays no dividend, but it pays a big yutairimawari.
  • This means Real World Float is 100% owned by retail who want restaurant coupons. This offering will be bought by index, short covers, and another 20-30k coupon holders.

Trading Considerations for Won Appreciation & Korean ADR Premium Volatility

By Sanghyun Park

  • Increased exchange rate volatility affects the ADR premium, but past patterns show that exchange rate and ADR premium directions may not always align, requiring consideration of specific contextual factors.
  • If the won appreciates below the 1,300s range, overseas institutions may shift to asymmetric selling of underlying shares for foreign exchange profit, as shown by rising ADR premiums.
  • We should watch for peak conditions to capture significant ADR premiums. Trading options include borrowing underlying shares for ADR conversion, even under the current short-selling ban.

Iriso Electronics (6908 JP): Murakami Becomes a Substantial Shareholder

By Arun George

  • Murakami’s entities, City Index Eleventh and Aya Nomura, reported a 5.06% position in Iriso Electronics (6908 JP). The purchases were from 25 July to 13 August.
  • Murakami’s average buy-in price over the last 60 days was JPY2,378.90 per share, a 7.8% discount to the last close price.
  • Murakami’s disclosure suggests two possibilities: the start of an activist campaign or a short-term pump-and-dump play. The former is likely as Iriso is cash-rich with a P/B less than 1x.

Guzman Y Gomez (GYG AU): Free Float to Determine Index Inclusion

By Brian Freitas

  • Guzman Y Gomez (GYG AU) listed on 20 June and is eligible for inclusion in the S&P/ASX family of indices at the September rebalance.
  • Whether the stock is included in indices depends on the index providers estimate of free float. We expect index providers to assign floats of between 25-35% for the stock.
  • Inclusion in one global index could come in November and another in December. Inclusion in the S&P/ASX indices will depend on whether float is higher than 30% or lower.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: Seven & I Holdings, Tokyo Metro, Weimob Inc., Apple , PropertyGuru , Peptron, Lumir, China Tower and more

By | Daily Briefs, Most Read

In today’s briefing:

  • MEGA M&A! 7&I (3382 JP) Gets Non-Binding Bid from Alimentation Couche-Tard (ATD CN)
  • Tokyo Metro IPO Early Look – Could Raise Around US$2bn While Still Recovering from COVID
  • Hang Seng Internet & IT Index Rebalance: Three Changes & A Few Surprises
  • Apple Inc (AAPL US): $43bn Passive Buying Driven by Berkshire Selling & Market Consultation
  • Seven & I Holdings (3382 JP): Couche-Tard “friendly” Proposal Likely to Go Nowhere
  • Apple (AAPL): Berkshire’s Sell-Off Triggers $37bn Demand from S&P 500
  • EQT’s Offer For PropertyGuru (NYSE:PGRU): As Clean As It Gets
  • Peptron Rights Issue: The 25% Discount Is an Attractive Outright Position Opportunity
  • Lumir IPO Preview
  • FXI Rebalance Preview: China Tower (788 HK) Could Replace CICC (3908 HK)


MEGA M&A! 7&I (3382 JP) Gets Non-Binding Bid from Alimentation Couche-Tard (ATD CN)

By Travis Lundy

  • Today, part-way through the day, the Nikkei ran an article saying that Alimentation Couche-Tard (ATD CN) had made a confidential non-binding proposal to buy Seven & I Holdings (3382 JP)
  • 7&i shares obviously went up (limit up in a hurry, staying there, large size traded limit up at close). 
  • Now things get complicated. 7&i has said they received a non-binding proposal for all the shares. There will be a Special Committee of all Independent Directors. All stakeholders will matter. 

Tokyo Metro IPO Early Look – Could Raise Around US$2bn While Still Recovering from COVID

By Sumeet Singh

  • Tokyo Metro (TKYMETRO JP)’s shareholders, the Japanese and Tokyo Metropolitan Governments, could look to raise up to US$2bn by selling half of their stake via an IPO.
  • Tokyo Metro is one of the two metro network operators in the Tokyo region. It operates nine subway lines.
  • In this note, we take an early look at the possible listing.

Hang Seng Internet & IT Index Rebalance: Three Changes & A Few Surprises

By Brian Freitas

  • There will be 3 changes for the Hang Seng Internet & Information Technology Index (HSIII) at the September rebalance. There are some surprises.
  • Estimated one-way turnover at the rebalance is 3.4% resulting in a round-trip trade of HK$2.04bn (US$262m). 7 stocks will have over 1x ADV to trade.
  • Weimob Inc. (2013 HK) is a surprise add. There is 6x ADV to buy from passive trackers and shorts are 12% of shares out and 24x ADV to cover.

Apple Inc (AAPL US): $43bn Passive Buying Driven by Berkshire Selling & Market Consultation

By Brian Freitas


Seven & I Holdings (3382 JP): Couche-Tard “friendly” Proposal Likely to Go Nowhere

By Arun George

  • Seven & I Holdings (3382 JP) shares rose 22.7% as it confirmed media reports that it had received a confidential, non-binding preliminary proposal from Alimentation Couche-Tard (ATD CN)
  • The interest is unsurprising due to the weak share price performance. Since ValueAct’s open letter on 25 January 2022, the shares are up 5.2% vs. the Nikkei 225 up 38.0%.
  • Couche-Tard aims for a friendly offer, which is challenging as it requires support from the founder’s family and the Japanese government. Therefore, the probability of a binding proposal is low.  

Apple (AAPL): Berkshire’s Sell-Off Triggers $37bn Demand from S&P 500

By Dimitris Ioannidis

  • Free float is forecasted to increase from ~94% to 100% in S&P 500 and other US and Global indices after Berkshire halved its stake in Apple (AAPL US) .
  • Forecasted demand from S&P 500 and S&P TMI is 164.2m shares, $37.1bn and 3.0 ADV at the close of 20 September 2024.
  • Materialization of the free float increase is uncertain due to debatable strategic shareholder classification. ETF ratios and current free float improve the confidence of the forecast. 

EQT’s Offer For PropertyGuru (NYSE:PGRU): As Clean As It Gets

By David Blennerhassett

  • Listed on the 18th March 2022 at US$8.33/share, Singaporean-based online real estate portal PropertyGuru (PGRU US) has now announced a US$6.70/share cash Offer from Sweden’s EQT AB.
  • That backs out a premium to undisturbed of 52%. Media speculation of a takeover for the TPG/KKR-backed PropertyGuru first surfaced around the 21st May this year. 
  • TPG and KKR, collectively holding ~56.1%, are supportive. REA Group Ltd (REA AU), holding 17.2%, is also on board. The key Offer condition is two-thirds of shareholders approving terms.

Peptron Rights Issue: The 25% Discount Is an Attractive Outright Position Opportunity

By Sanghyun Park

  • Peptron’s lack of single-stock futures means no risk-free arbitrage but also less speculative selling, making the 25% discount an attractive outright position opportunity.
  • The low capital increase rate may stabilize the stock price, and more forfeited shares could lower the cost of securing subscription rights during the trading window.
  • Consider buying rights during the trading period or targeting forfeited shares. Conservatively estimate the final offering price range to set a profitable cost for securing rights.

Lumir IPO Preview

By Douglas Kim

  • Lumir is getting ready to complete its IPO on KOSDAQ in September. The IPO which is expected to raise between 49.5 billion won to 61.5 billion won.
  • Lumir specializes in the development of observation satellite technology including image data processing devices and onboard computers for a number of government satellite series.
  • Lumir had sales of 12.1 billion won (up 90.5% YoY) in 2023. Its sales surged by 477% YoY to reach 8.2 billion won in 1H24.

FXI Rebalance Preview: China Tower (788 HK) Could Replace CICC (3908 HK)

By Brian Freitas


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Most Read: Sun Corp, CPMC Holdings, Weimob Inc., ASM Pacific Technology, Tencent, J&T Global Express , Hang Seng Index, Apple and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Sun Corp (6736) – The Future Is Bright
  • HSCEI Index Rebalance: Three In-Line Changes, Two Big Surprises
  • HSCI Index Rebalance: 38 Adds, 29 Deletes & Changes to Southbound Stock Connect
  • Hang Seng Internet & IT Index Rebalance: Three Changes & A Few Surprises
  • HSTECH Index Rebalance: ASMPT (522 HK) Replaces Ping An Healthcare (1833 HK)
  • Hang Seng Index Sep24 Rebal – No Name Changes, Some Capping, 1% One-Way Flow – Total 0️⃣🍔
  • HSCEI Sep24 Rebal – Two ADDs, Two DELETEs, Two Surprises, Middling Flows
  • Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)
  • Apple Inc (AAPL US): $43bn Passive Buying Driven by Berkshire Selling & Market Consultation
  • Sep24 HSTECH Index Rebal – ASMPT (522 HK) ADDed as Expected, After Post-Earnings Fall


Sun Corp (6736) – The Future Is Bright

By Travis Lundy

  • The reason why Sun Corp (6736 JP) has traditionally traded at a large discount to its potential outcome is the possibility of inefficient or delayed value realisation. 
  • Materially ALL of the value of the company is in its holding in Cellebrite DI (CLBT US). True Wind Capital, the SPAC sponsor of CLBT, just bought 19% of SunCorp. 
  • They bought that for the CLBT, or the value realisation thereof. And now with the slightly surprising Tender Offer result, the chances of a better outcome are now higher.

HSCEI Index Rebalance: Three In-Line Changes, Two Big Surprises

By Brian Freitas


HSCI Index Rebalance: 38 Adds, 29 Deletes & Changes to Southbound Stock Connect

By Brian Freitas

  • There are 38 adds and 29 deletes for the Hang Seng Composite Index (HSCI) at the September rebalance to take the number of index constituents up to 518.
  • We expect 33 of the 38 HSCI inclusions to be added to Stock Connect while we expect 27 of the 29 HSCI deletions to be removed from Southbound Stock Connect.
  • Since the start of the calendar year, shares held though Southbound Connect have increased in 22 of the 27 HSCI deletions that will also be removed from Stock Connect.

Hang Seng Internet & IT Index Rebalance: Three Changes & A Few Surprises

By Brian Freitas

  • There will be 3 changes for the Hang Seng Internet & Information Technology Index (HSIII) at the September rebalance. There are some surprises.
  • Estimated one-way turnover at the rebalance is 3.4% resulting in a round-trip trade of HK$2.04bn (US$262m). 7 stocks will have over 1x ADV to trade.
  • Weimob Inc. (2013 HK) is a surprise add. There is 6x ADV to buy from passive trackers and shorts are 12% of shares out and 24x ADV to cover.

HSTECH Index Rebalance: ASMPT (522 HK) Replaces Ping An Healthcare (1833 HK)

By Brian Freitas


Hang Seng Index Sep24 Rebal – No Name Changes, Some Capping, 1% One-Way Flow – Total 0️⃣🍔

By Travis Lundy

  • The Hang Seng Index Committee its slow move (lack of movement) towards 100 names and sector rebalancing to tech and healthcare. This is really disappointing.
  • This time? We get nothing. No name changes. Some capping flows. 6 FAF changes. 
  • Minimal flows on the HSI rebalance to be effective on 9 September. 

HSCEI Sep24 Rebal – Two ADDs, Two DELETEs, Two Surprises, Middling Flows

By Travis Lundy


Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)

By Brian Freitas

  • In a surprise (maybe should not have been!), there are no constituent changes for the Hang Seng Index (HSI INDEX) in September. However, there are float and capping changes.
  • Estimated one-way turnover is 1% and estimated round-trip trade is HK$3.73bn (US$478m). There are no stocks with over +/-0.5x ADV to trade but flows could add to/offset other index flows.
  • We remain at 82 index constituents and the road to 100 constituents appears to be a long drawn out torturous one. At this glacial pace, could be an eternity away.

Apple Inc (AAPL US): $43bn Passive Buying Driven by Berkshire Selling & Market Consultation

By Brian Freitas


Sep24 HSTECH Index Rebal – ASMPT (522 HK) ADDed as Expected, After Post-Earnings Fall

By Travis Lundy


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars